NASDAQ
ABVC BioPharma, Inc. (ABVC) has a current ratio of 0.41x as of Monday, May 25, 2026. This represents a 49.52% decrease compared to its 12-month average of 0.80x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.